PROF · Company research
Profound Medical Corp. Common Stock (PROF): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
25records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| LS Leading Solution Prof PF Note 13 (K55368BB2909.KS) interactive stock chart - Yahoo Finance UK | LS Leading Solution Prof PF Note 13 (K55368BB2909.KS) interactive stock chart Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 14, 2026 | neutral | 0 | 0.6 |
| Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect? | Profound Medical (PROF) closed at $7.01 with a mean analyst price target of $11.13, suggesting 58.8% upside potential. The stock has gained 23.4% over the past four weeks. Analysts have revised earnings estimates higher over the last 30 days, and PROF holds a Zacks Rank #2 (Buy) rating. However, the article cautions that price targets can be misleading and should not be the sole basis for investment decisions. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | bullish | 1 | 1 |
| Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect? | Profound Medical (PROF) closed at $7.01 with a mean analyst price target of $11.13, suggesting 58.8% upside potential. The stock has gained 23.4% over the past four weeks. Analysts have revised earnings estimates higher over the last 30 days, and PROF holds a Zacks Rank #2 (Buy) rating. However, the article cautions that price targets can be misleading and should not be the sole basis for investment decisions. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | bullish | 1 | 1 |
| Sexual function and continence outcomes separate treatments in Profound Medical (PROF)'s six-month trial. - Stock Titan | Sexual function and continence outcomes separate treatments in Profound Medical (PROF)'s six-month trial. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| A prostate treatment passed technical tests on a less powerful MRI machine; patient use there is unproven. - Stock Titan | A prostate treatment passed technical tests on a less powerful MRI machine; patient use there is unproven. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| How Profound Medical Corp. (PROF) Affects Rotational Strategy Timing - Stock Traders Daily | How Profound Medical Corp. (PROF) Affects Rotational Strategy Timing Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 13, 2026 | neutral | 0 | 0.6 |
| How Profound Medical Corp. (PROF) Affects Rotational Strategy Timing - Stock Traders Daily | How Profound Medical Corp. (PROF) Affects Rotational Strategy Timing Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 13, 2026 | neutral | 0 | 0.6 |
| LS Leading Solution Prof PF Note 13 (K55368BB2909.KS) Latest Stock News & Headlines - Yahoo! Finance Canada | LS Leading Solution Prof PF Note 13 (K55368BB2909.KS) Latest Stock News & Headlines Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 10, 2026 | neutral | 0 | 0.6 |
| Profound Medical: Q3 Revenue Beats Outlook (Rating Upgrade) - Seeking Alpha | Profound Medical: Q3 Revenue Beats Outlook (Rating Upgrade) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 9, 2026 | neutral | 0 | 0.6 |
| The companies plan to teach doctors how prostate scans complement MRI-guided treatment. - Stock Titan | The companies plan to teach doctors how prostate scans complement MRI-guided treatment. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? | Profound Medical (PROF) surged 21.7% following strong preliminary Q3 2026 revenue guidance of $9.8-10 million, representing 85-89% year-over-year growth and 45-47% above analyst consensus. The company expects gross margins exceeding 70%, signaling improved commercial momentum. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the stock's momentum may not sustain without further positive estimate revisions. | View source ↗ | Zacks Investment Research | Oct 9, 2026 | bullish | 0.5 | 1 |
| Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? | Profound Medical (PROF) surged 21.7% following strong preliminary Q3 2026 revenue guidance of $9.8-10 million, representing 85-89% year-over-year growth and 45-47% above analyst consensus. The company expects gross margins exceeding 70%, signaling improved commercial momentum. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the stock's momentum may not sustain without further positive estimate revisions. | View source ↗ | Zacks Investment Research | Oct 9, 2026 | bullish | 0.5 | 1 |
| Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? - Yahoo Finance Australia | Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 9, 2026 | neutral | 0 | 0.6 |
| Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? - Yahoo! Finance Canada | Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| 12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga | 12 Health Care Stocks Moving In Thursday's Pre-Market Session Benzinga | View source ↗ | Benzinga | Oct 8, 2026 | neutral | 0 | 0.6 |
| Chula & Stock Exchange of Thailand Join Forces - QS GEN | Chula & Stock Exchange of Thailand Join Forces QS GEN | View source ↗ | QS GEN | Oct 8, 2026 | neutral | 0 | 0.6 |
| Profound Medical (NasdaqCM:PROF) Stock Forecast & Analyst Predictions - Simply Wall Street | Profound Medical (NasdaqCM:PROF) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 8, 2026 | neutral | 0 | 0.6 |
| Let's take a look at the stocks that are in motion in today's session. - ChartMill | Let's take a look at the stocks that are in motion in today's session. ChartMill | View source ↗ | ChartMill | Oct 8, 2026 | neutral | 0 | 0.6 |
| Revenue is expected to nearly quadruple from Q2 at Profound Medical. - Stock Titan | Revenue is expected to nearly quadruple from Q2 at Profound Medical. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Profound Medical (PROF) Projects Strong Q3 Revenue Growth, Shares Jump 16% - GuruFocus | Profound Medical (PROF) Projects Strong Q3 Revenue Growth, Shares Jump 16% GuruFocus | View source ↗ | GuruFocus | Oct 7, 2026 | neutral | 0 | 0.6 |
| Discipline and Rules-Based Execution in PROF Response - Stock Traders Daily | Discipline and Rules-Based Execution in PROF Response Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 3, 2026 | neutral | 0 | 0.6 |
| Discipline and Rules-Based Execution in PROF Response - Stock Traders Daily | Discipline and Rules-Based Execution in PROF Response Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 3, 2026 | neutral | 0 | 0.6 |
| Prof G admits his ‘emotional reaction’ to Trump lost him 40% of net worth in stocks: ‘That was stupid’ - Yahoo Finance | Prof G admits his ‘emotional reaction’ to Trump lost him 40% of net worth in stocks: ‘That was stupid’ Yahoo Finance | View source ↗ | Yahoo Finance | Oct 2, 2026 | neutral | 0 | 0.6 |
| Trump-hating podcaster, NYU prof regrets ‘stupid’ decision to sell off stocks after 2016 win: ‘Biggest investment mistake’ - New York Post | Trump-hating podcaster, NYU prof regrets ‘stupid’ decision to sell off stocks after 2016 win: ‘Biggest investment mistake’ New York Post | View source ↗ | New York Post | Sep 29, 2026 | neutral | 0 | 0.6 |
| Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last? - Yahoo Finance | Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 7, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.